Management of Neurosurgical Patients During the COVID-19 Pandemic

Author:

Shi Huaizhang1,Yang Guang1ORCID,Gao Cheng1,Wang Xiaoxiong1,Xin Guan1,Rui Luan1,Gareev I. F.2ORCID,Beylerli O. A.2ORCID,Gantsev Sh. Kh.2ORCID,Zhao Shiguang1ORCID

Affiliation:

1. First Affiliated Hospital of Harbin Medical University

2. Bashkir State Medical University

Abstract

The 2019 coronavirus infection (COVID-19) is a dangerous infectious disease proceeding as an acute respiratory viral infection with specific complications, which may include pneumonia leading to acute respiratory distress syndrome or respiratory failure with a high risk of death. The etiological agent of COVID-19 is a new coronavirus, referred to as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This new viral form is most likely to have appeared from zoonotic coronaviruses, such as SARS-CoV emerged in 2002. This article sets out to present a strategy for manag‑ ing neurosurgical patients, which was developed taking into account the experience of the Neurosurgery Department of the First Affiliated Hospital of Harbin Medical University in the prevention and control of pneumonia outbreaks caused by the new coronavirus. This strategy can be helpful for neurosurgeons in providing emergency care in the context of the COVID-19 pandemic in the Russian Federation.

Publisher

Bashkir State Medical University

Subject

General Engineering,Energy Engineering and Power Technology

Reference10 articles.

1. Kannan S., Shaik Syed Ali P., Sheeza A., Hemalatha K. COVID-19 (Novel Coronavirus 2019) — recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006–11. DOI: 10.26355/eurrev_202002_20378

2. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–6. DOI: 10.1007/s12098-020-03263-6

3. Sifuentes-Rodríguez E., Palacios-Reyes D. COVID-19: The outbreak caused by a new coronavirus. Bol Med Hosp Infant Mex. 2020;77(2):47–53. DOI: 10.24875/BMHIM.20000039

4. Trojánek M., Grebenyuk V., Herrmannová K., Nečas T., Gregorová J., Kucbel M., et al. A novel coronavirus (SARS-CoV-2) and COVID-19. Cas Lek Cesk. 2020;159(2):55–66.

5. National health commission of the People’s Republic of China [Internet]. Diagnosis and treatment scheme of Covid-19 (Sixth Trial Version) [cited 2020 Sept 27]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Therapeutic potential of the stromal vascular fraction in COVID-19;HERALD of North-Western State Medical University named after I.I. Mechnikov;2021-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3